Musculoskeletal companies develop therapies, diagnostics and technologies for conditions affecting bones, joints, muscles, tendons and connective tissues. Their work supports pain management, tissue repair, mobility and the treatment of chronic and degenerative disease.
This category includes companies working on:
Browse 26 UK musculoskeletal companies below.
Clinical-stage rare disease biotech acquiring deprioritised pharma assets
Mereo BioPharma is a clinical-stage biopharmaceutical company focused on developing treatments for rare diseases. Founded in 2015, its business model centres on acquiring…
Contract development and manufacture of nanofibrous biomaterials for medical devices
The Electrospinning Company designs, develops, and manufactures nanofibrous biomaterials for implantable medical devices and regenerative medicine applications. Using…
Extracellular vesicle platform for consistent, scalable regenerative therapeutics
Mesenbio is a preclinical-stage biopharmaceutical company developing a cell line platform that produces a consistent, scalable supply of therapeutic extracellular vesicles,…
AI-driven target discovery from human tissue omics
Relation is a platform biotechnology company integrating machine learning with single-cell and spatial multi-omics data derived directly from patient tissue to discover and…
Calcium-compound bone and antibiotic-carrier devices for surgical infection management
Biocomposites is a UK-based medical device company that engineers, manufactures and markets calcium compound devices for infection management in bone and soft tissue. Its product…
Medical imaging CRO and AI platform for clinical trials
Image Analysis Group is a specialist imaging contract research organisation serving biotech and pharmaceutical companies across all clinical trial phases. The company designs and…
CSF-1R antibody therapy for tenosynovial giant cell tumour
SynOx Therapeutics is a late-stage biopharmaceutical company developing emactuzumab, a humanised monoclonal antibody targeting CSF-1R, for the treatment of tenosynovial giant cell…
Synthetic platform for precision delivery of biologics in tissue repair
Renovos Biologics is a biotech company developing precision delivery technologies for regenerative medicine, drawing on decades of academic research in skeletal stem cells,…
Stem cell therapies for equine musculoskeletal injuries
BioDivide Limited is a regenerative medicine company developing and commercialising stem cell therapies, with a current focus on equine musculoskeletal conditions. Its product…
Silicon-based RNA delivery platform for rare disease therapeutics
SiSaf is a biopharmaceutical company developing RNA therapeutics using its proprietary platform, which combines bioabsorbable silicon with organic lipid materials to improve the…
AI-driven isoform sequencing platform for movement disorder and ageing research
Entelo Bio is an Oxford-based biotechnology company developing a proprietary single-cell isoform sequencing and AI platform to decode disease biology in conditions affecting human…
Lab-grown human muscle platform for preclinical drug testing and safety assessment
Myomaker Bio is a UK-based CRO specialising in pre-clinical muscle biology. The company has developed a platform of lab-grown human skeletal muscle tissues and organs that…